Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02846870 · ClinicalTrials.gov registry record · NA
Visually Enhanced Education About Prostate Cancer
A NA study of Stage I Prostate Cancer and Stage III Prostate Cancer, sponsored by Vanderbilt-Ingram Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT02846870: Completed NA study of Stage I Prostate Cancer and Stage III Prostate Cancer, sponsored by Vanderbilt-Ingram Cancer Center.
NCT02846870 is a NA study of Stage I Prostate Cancer and Stage III Prostate Cancer that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 30 participants, below the 57-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02846870, a NA study of Stage I Prostate Cancer and Stage III Prostate Cancer, has completed, sponsored by Vanderbilt-Ingram Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized clinical trial studies how well visually enhanced education works in improving prostate cancer and treatment knowledge in patients with prostate cancer that has not spread to other places in the body. Visually enhanced education includes pictures, drawings, and photos, may help doctors better convey information about radiation and prostate cancer to patients.
Primary Outcome
Sample size was determined based on this primary outcome - with estimated mean of 16 in Arm A and mean of 8 in Arm B, with standard deviation of 15, with 80% power and alpha of 0.05.
Conditions Studied
Interventions
- OTHER Visually enhanced prostate cancer educational presentation
- OTHER Standard prostate cancer education presentation
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2016-09 |
| Est. Completion | 2018-08 |
| Phase | NA |
What the finished NCT02846870 record still lists
NCT02846870 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 57-participant average among 9 other Stage I Prostate Cancer trials with a reported enrollment target (47% lower).
The record links to 3 conditions, with Stage I Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Visually enhanced prostate cancer educational presentation is the first listed.
NCT02846870 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT02846870 about?
NCT02846870 is a clinical study titled "Visually Enhanced Education About Prostate Cancer". This randomized clinical trial studies how well visually enhanced education works in improving prostate cancer and treatment knowledge in patients with prostate cancer that has not spread to other places in the body. Visually enhanced education includes pictures, drawings, and photos, may help docto...
What is the current status of trial NCT02846870?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2016-09. Estimated completion is 2018-08.
What conditions does trial NCT02846870 study?
This clinical trial studies the following conditions: Stage I Prostate Cancer, Stage III Prostate Cancer, Stage II Prostate Cancer.
What interventions are being tested in trial NCT02846870?
The interventions under investigation include: Visually enhanced prostate cancer educational presentation (OTHER), Standard prostate cancer education presentation (OTHER).
Who is sponsoring clinical trial NCT02846870?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02846870 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stage I Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02846870's enrollment target sits among peer trials
30 7th of 9 higher than 3 of 9 other Stage I Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stage I Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nutrition and Exercise Interventions in Reducing Androgen Deprivation Therapy-Induced Obese Frailty in Prostate Cancer Survivors
RECRUITING · NA
-
Low-Fat Diet and Fish Oil in Men on Active Surveillance for Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
High-Dose Brachytherapy in Treating Patients With Prostate Cancer
ACTIVE NOT RECRUITING · NA
-
Researching the Effect of Exercise on Cancer
ACTIVE NOT RECRUITING · NA
-
MR-Guided Laser Interstitial Thermal Therapy in Treating Patients With Prostate Cancer
COMPLETED · NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery
ACTIVE NOT RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia